Hormone-refractory Prostate Cancer
4 drugs829 FAERS reportsMedDRA PT
GET
/api/v1/reaction/hormone-refractory-prostate-cancerReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Hormone-refractory Prostate Cancer (4)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Radium4356.2%
- 2Darolutamide1282.5%
- 3Tetraxetan1331.1%
- 4Vipivotide Tetraxetan1331.1%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Prostate Cancer4 shared · 0.44
- Sars-cov-2 Test Positive2 shared · 0.33
- Prostate Cancer Metastatic2 shared · 0.29
- Prostatic Specific Antigen Increased4 shared · 0.25
- Metastases To Bone4 shared · 0.24
- Laboratory Test Abnormal2 shared · 0.17
- Ill-defined Disorder2 shared · 0.10
- Dry Mouth2 shared · 0.04
- General Physical Health Deterioration3 shared · 0.04
- Haemoglobin Decreased3 shared · 0.03
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.